Literature DB >> 23295400

A history of chronic morphine exposure during adolescence increases despair-like behaviour and strain-dependently promotes sociability in abstinent adult mice.

P E Lutz1, D Reiss, A M Ouagazzal, B L Kieffer.   

Abstract

A crucial issue in treating opiate addiction, a chronic relapsing disorder, is to maintain a drug-free abstinent state. Prolonged abstinence associates with mood disorders, strongly contributing to relapse. In particular, substance use disorders occurring during adolescence predispose to depression later in adulthood. Using our established mouse model of opiate abstinence, we characterized emotional consequences into adulthood of morphine exposure during adolescence. Our results indicate that morphine treatment in adolescent mice has no effect on anxiety-like behaviours in adult mice, after abstinence. In contrast, morphine treatment during adolescence increases behavioural despair in adult mice. We also show that morphine exposure strain-dependently enhances sociability in adult mice. Additional research will be required to understand where and how morphine acts during brain maturation to affect emotional and social behaviours into adulthood.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23295400      PMCID: PMC3594412          DOI: 10.1016/j.bbr.2012.12.049

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  97 in total

1.  Mu opioid receptor coupling to Gi/o proteins increases during postnatal development in rat brain.

Authors:  Jeffery N Talbot; H Kevin Happe; L Charles Murrin
Journal:  J Pharmacol Exp Ther       Date:  2005-04-28       Impact factor: 4.030

Review 2.  A neurobehavioral model of affiliative bonding: implications for conceptualizing a human trait of affiliation.

Authors:  Richard A Depue; Jeannine V Morrone-Strupinsky
Journal:  Behav Brain Sci       Date:  2005-06       Impact factor: 12.579

3.  Augmented accumbal serotonin levels decrease the preference for a morphine associated environment during withdrawal.

Authors:  G C Harris; G Aston-Jones
Journal:  Neuropsychopharmacology       Date:  2001-01       Impact factor: 7.853

4.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

5.  Gender and comorbidity among individuals with opioid use disorders in the NESARC study.

Authors:  Christine E Grella; Mitchell P Karno; Umme S Warda; Noosha Niv; Alison A Moore
Journal:  Addict Behav       Date:  2009-01-30       Impact factor: 3.913

6.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

7.  Behavioral and neurochemical changes induced by oxycodone differ between adolescent and adult mice.

Authors:  Yong Zhang; Roberto Picetti; Eduardo R Butelman; Stefan D Schlussman; Ann Ho; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2008-09-10       Impact factor: 7.853

8.  Differential entrainment of a social rhythm in adolescent mice.

Authors:  Jules B Panksepp; Jenny C Wong; Bruce C Kennedy; Garet P Lahvis
Journal:  Behav Brain Res       Date:  2008-09-18       Impact factor: 3.332

9.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

Review 10.  Are adolescents more vulnerable to drug addiction than adults? Evidence from animal models.

Authors:  Nicole L Schramm-Sapyta; Q David Walker; Joseph M Caster; Edward D Levin; Cynthia M Kuhn
Journal:  Psychopharmacology (Berl)       Date:  2009-06-23       Impact factor: 4.530

View more
  8 in total

Review 1.  Substance use modulates stress reactivity: Behavioral and physiological outcomes.

Authors:  Anne Q Fosnocht; Lisa A Briand
Journal:  Physiol Behav       Date:  2016-02-19

2.  Dissociation of heroin-induced emotional dysfunction from psychomotor activation and physical dependence among inbred mouse strains.

Authors:  G Ayranci; K Befort; L Lalanne; B L Kieffer; P-E Lutz
Journal:  Psychopharmacology (Berl)       Date:  2014-12-09       Impact factor: 4.530

Review 3.  The multiple facets of opioid receptor function: implications for addiction.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Curr Opin Neurobiol       Date:  2013-02-28       Impact factor: 6.627

4.  Long-lasting effects of adolescent oxycodone exposure on reward-related behavior and gene expression in mice.

Authors:  Victoria Sanchez; Marco D Carpenter; Nicole L Yohn; Julie A Blendy
Journal:  Psychopharmacology (Berl)       Date:  2016-09-13       Impact factor: 4.530

5.  Differential behavioral and molecular alterations upon protracted abstinence from cocaine versus morphine, nicotine, THC and alcohol.

Authors:  Jérôme A J Becker; Brigitte L Kieffer; Julie Le Merrer
Journal:  Addict Biol       Date:  2016-04-28       Impact factor: 4.280

6.  Distinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence.

Authors:  Pierre-Eric Lutz; Gulebru Ayranci; Paul Chu-Sin-Chung; Audrey Matifas; Pascale Koebel; Dominique Filliol; Katia Befort; Abdel-Mouttalib Ouagazzal; Brigitte L Kieffer
Journal:  Neuropsychopharmacology       Date:  2014-05-30       Impact factor: 7.853

Review 7.  The influence of stress and early life adversity on addiction: Psychobiological mechanisms of risk and resilience.

Authors:  Mustafa al'Absi
Journal:  Int Rev Neurobiol       Date:  2020-05-04       Impact factor: 4.280

Review 8.  The kappa opioid receptor: from addiction to depression, and back.

Authors:  Laurence Lalanne; Gulebru Ayranci; Brigitte L Kieffer; Pierre-Eric Lutz
Journal:  Front Psychiatry       Date:  2014-12-08       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.